Zacks Research Issues Negative Outlook for Avantor Earnings

Avantor, Inc. (NYSE:AVTR) – Research analysts at Zacks Research reduced their Q3 2025 earnings per share (EPS) estimates for Avantor in a report issued on Friday, October 18th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share of $0.28 for the quarter, down from their previous estimate of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. Zacks Research also issued estimates for Avantor’s Q4 2025 earnings at $0.35 EPS and FY2026 earnings at $1.35 EPS.

Other equities research analysts also recently issued research reports about the stock. UBS Group reduced their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Barclays boosted their price target on Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Wells Fargo & Company began coverage on Avantor in a research report on Tuesday, August 27th. They set an “overweight” rating and a $30.00 price objective on the stock. Evercore ISI decreased their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. Finally, Morgan Stanley upped their target price on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $28.00.

Avantor Stock Performance

Shares of AVTR stock opened at $24.49 on Monday. The company has a market capitalization of $16.64 billion, a price-to-earnings ratio of 62.79, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. Avantor has a one year low of $16.63 and a one year high of $28.00. The company’s 50-day moving average is $25.65 and its 200 day moving average is $24.32.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion.

Institutional Trading of Avantor

Several hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc raised its stake in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. grew its stake in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after buying an additional 1,391 shares during the last quarter. UMB Bank n.a. purchased a new stake in shares of Avantor in the third quarter worth approximately $49,000. GAMMA Investing LLC lifted its stake in shares of Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares during the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in Avantor in the 1st quarter valued at $93,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 1.50% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.